Liquid versus tissue biopsy for detecting actionable alterations according to the ESMO Scale for Clinical Actionability of molecular Targets in patients with advanced cancer: a study from the French National Center for Precision Medicine (PRISM)

Arnaud Bayle, Florent Peyraud, Laïla Belcaid, M. Brunet, Mihaela Aldea, R. Clodion, P. Dubos, Damien Vasseur, Claudio Nicotra, Arthur Géraud, Madona Sakkal, Luigi Cerbone, Félix Blanc‐Durand, Fernanda Mosele, Paola Romano, Maud Ngo Camus, Isabelle Soubeyran, Emmanuel Khalifa, Melissa Alamé, L. Blouin, Derek Dinart, Carine Bellera, Antoine Hollebecque, Santiago Ponce, Yohann Loriot, Benjamin Besse, Ludovic Lacroix, Etienne Rouleau, Fabrice Barlési, Fabrice André, Antoîne Italiano